(R)-4-乙基-4-羟基-1,12-二氢-14H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-3,14(4H)-二酮

(R)-(-)-Camptothecin

产品编号.: A351923 CAS号: 110351-92-3
分子式: C20H16N2O4 分子量: 348.3520
纯度: 95% MDL NO.:

中文名称:(R)-4-乙基-4-羟基-1,12-二氢-14H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-3,14(4H)-二酮
CAS号:110351-92-3
中文别名:右旋喜树碱;20R-喜树碱
英文名称:(R)-(-)-Camptothecin
英文别名:1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, (4R)-;20R-Camptothecin;(R)-(-)-Camptothecin;(4R)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(R)-(-)-Camptothecine;(R)-4-Ethyl-4-hydroxy-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(R)-Camptothecin;(4R)-4β-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;TNP00113;crlx101;(20R)-Camptothecin;BDBM50406992;(alphaR)-alpha-Ethyl-alpha-hydroxy-8-(hydr;CS-0164099;CCG-36183;NCGC00017231-02;NCGC00142465-01;110351-92-3;NCGC00017231-01;CHEMBL71836;(19R)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;(R)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione? (Irinotecan Impurity pound(c);DTXSID80149224;SCHEMBL4304557;(S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
EINECS:
分子式:C20H16N2O4
分子量:348.3520
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

(R)-4-乙基-4-羟基-1,12-二氢-14H-吡喃并[3',4':6,7]吲哚嗪并[1,2-b]喹啉-3,14(4H)-二酮
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, (4R)-;20R-Camptothecin;(R)-(-)-Camptothecin;(4R)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(R)-(-)-Camptothecine;(R)-4-Ethyl-4-hydroxy-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(R)-Camptothecin;(4R)-4β-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;TNP00113;crlx101;(20R)-Camptothecin;BDBM50406992;(alphaR)-alpha-Ethyl-alpha-hydroxy-8-(hydr;CS-0164099;CCG-36183;NCGC00017231-02;NCGC00142465-01;110351-92-3;NCGC00017231-01;CHEMBL71836;(19R)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;(R)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione? (Irinotecan Impurity pound(c);DTXSID80149224;SCHEMBL4304557;(S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione